Weighted Average Number of Shares Outstanding, Basic of NEUROCRINE BIOSCIENCES INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Neurocrine Biosciences Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2010 to Q3 2025.
  • Neurocrine Biosciences Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 99.4M shares, a 1.68% decline year-over-year.
  • Neurocrine Biosciences Inc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 100M shares, a 2.76% increase from 2023.
  • Neurocrine Biosciences Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 97.7M shares, a 1.98% increase from 2022.
  • Neurocrine Biosciences Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 95.8M shares, a 1.27% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

NEUROCRINE BIOSCIENCES INC Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 99.4M -1.7M -1.68% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-28
Q2 2025 99M -1.8M -1.79% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-30
Q1 2025 99.7M -100K -0.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q4 2024 100M +2.7M +2.76% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-10
Q3 2024 101M +3.2M +3.27% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-28
Q2 2024 101M +3.2M +3.28% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-30
Q1 2024 99.8M +2.7M +2.78% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q4 2023 97.7M +1.9M +1.98% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-10
Q3 2023 97.9M +2.1M +2.19% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 97.6M +2M +2.09% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 97.1M +1.8M +1.89% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 95.8M +1.2M +1.27% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-10
Q3 2022 95.8M +1.1M +1.16% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 95.6M +1M +1.06% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 95.3M +1.1M +1.17% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 94.6M +1.1M +1.18% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-09
Q3 2021 94.7M +1.4M +1.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 94.6M +1.6M +1.72% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 94.2M +1.6M +1.73% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 93.5M +1.3M +1.41% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-05
Q3 2020 93.3M +1.4M +1.52% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 93M +1.6M +1.75% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 92.6M +1.5M +1.65% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 92.2M +1.46M +1.61% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-05
Q3 2019 91.9M +1.35M +1.49% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-05
Q2 2019 91.4M +1.3M +1.44% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-05
Q1 2019 91.1M +1.57M +1.76% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-05
Q4 2018 90.7M +2.08M +2.34% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-07
Q3 2018 90.6M +2.23M +2.53% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-07
Q2 2018 90.1M +2.04M +2.31% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-07
Q1 2018 89.5M +2.24M +2.57% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-07
Q4 2017 88.7M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-08
Q3 2017 88.3M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-08
Q2 2017 88.1M Apr 1, 2017 Jun 30, 2017 10-K 2019-02-08
Q1 2017 87.3M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-08
Q4 2013 67.3M +940K +1.42% Oct 1, 2013 Dec 31, 2013 10-K 2014-02-11
Q3 2013 67.2M +857K +1.29% Jul 1, 2013 Sep 30, 2013 10-K 2014-02-11
Q2 2013 66.8M +490K +0.74% Apr 1, 2013 Jun 30, 2013 10-K 2014-02-11
Q1 2013 66.6M +3.19M +5.03% Jan 1, 2013 Mar 31, 2013 10-K 2014-02-11
Q4 2012 66.4M +11.1M +20.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-11
Q3 2012 66.3M +11.1M +20.1% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-11
Q2 2012 66.3M +11.1M +20.1% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-11
Q1 2012 63.4M +8.43M +15.3% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-11
Q4 2011 55.3M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-08
Q3 2011 55.2M +404K +0.74% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-08
Q2 2011 55.2M +373K +0.68% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-08
Q1 2011 55M Jan 1, 2011 Mar 31, 2011 10-K 2013-02-08
Q3 2010 54.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 54.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-29

NEUROCRINE BIOSCIENCES INC Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 100M +2.7M +2.76% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-10
2023 97.7M +1.9M +1.98% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-10
2022 95.8M +1.2M +1.27% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-10
2021 94.6M +1.5M +1.61% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-09
2020 93.1M +1.5M +1.64% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 91.6M +1.4M +1.55% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
2018 90.2M +2.11M +2.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-05
2017 88.1M +1.38M +1.59% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-07
2016 86.7M +2.22M +2.62% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-08
2015 84.5M +9.92M +13.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-13
2014 74.6M +7.59M +11.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-14
2013 67M +1.37M +2.09% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-11
2012 65.6M +10.4M +18.9% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-09
2011 55.2M +2.36M +4.46% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-11
2010 52.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.